SCHEMBL30080002

SCHEMBL30080002

CCOC(=O)c1nocc1CO

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.41
ALDH1A1 P00352 3/20 0.41
CYP1A2 P05177 2/20 0.41
POLB P06746 1/20 0.40
HPGD P15428 1/20 0.40
TARBP2 Q15633 4/20 0.39
HTT P42858 1/20 0.39
ELANE P08246 2/20 0.38
MAPT P10636 2/20 0.38
PKM P14618 2/20 0.38
KMT2A Q03164 2/20 0.38
LMNA P02545 1/20 0.38
MEN1 O00255 1/20 0.38
TSHR P16473 1/20 0.38
MAPK1 P28482 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30487833 0.85 TARBP2 (0.40) KDM4EALDH1A1CYP1A2HPGDTARBP2
SCHEMBL5801249 0.85 LMNA (0.44) KDM4EALDH1A1CYP1A2HPGDTARBP2
SCHEMBL23986023 0.81 HDAC4 (0.42) KDM4ECYP1A2HPGDTARBP2HTT
SCHEMBL6873803 0.81 HPGD (0.43) KDM4EALDH1A1CYP1A2POLBHPGD
SCHEMBL8920076 0.79 CA12 (0.46) KDM4EALDH1A1CYP1A2HPGDTARBP2
SCHEMBL22727456 0.78 TARBP2 (0.44) KDM4EALDH1A1CYP1A2POLBHPGD
SCHEMBL26921830 0.78 HTT (0.46) KDM4EALDH1A1CYP1A2HPGDTARBP2
SCHEMBL30173675 0.77 HDAC4 (0.42) KDM4EALDH1A1HPGDTARBP2HTT
SCHEMBL23990453 0.77 CYP1A2 (0.42) KDM4EALDH1A1CYP1A2HPGDTARBP2
SCHEMBL16571753 0.77 HTT (0.48) ALDH1A1POLBHPGDTARBP2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110650955-B Compounds for the treatment of epilepsy, neurodegenerative disorders and other CNS disorders 瑞敏德股份有限公司 2023-07-25 CN disclosed
CN-112204036-B Macrocyclic fused pyrazoles as MCL-1 inhibitors 苏州亚盛药业有限公司 2022-12-27 CN disclosed